PlainRecalls
FDA Drug Moderate Class II Terminated

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

Reported: April 28, 2021 Initiated: April 16, 2021 #D-0336-2021

Product Description

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

Reason for Recall

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Details

Recalling Firm
Noven Pharmaceuticals Inc
Units Affected
12060 cartons
Distribution
Nationwide within the United States
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8. Recalled by Noven Pharmaceuticals Inc. Units affected: 12060 cartons.
Why was this product recalled?
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 28, 2021. Severity: Moderate. Recall number: D-0336-2021.